Tag: Education

When were you diagnosed with secondary breast cancer? I was diagnosed back in July 2012.

What is Trastuzumab Emtansine Trastuzumab emtansine is a type of targeted cancer drug. It is also known by its brand name Kadcyla and TDM1.

Gill Cory continues her 'SBC & Me' story.

What is Everolimus Everolimus is a targeted cancer drug that blocks cancer growth. You might have everolimus if you have advanced breast cancer that is hormone receptor positive.

Rachel Stewart continues her 'SBC & Me' story.

What is Pertuzamab Pertuzumab is a targeted cancer drug and is also known by its brand name Perjeta. What is it?It is a treatment for breast cancer.

When were you diagnosed with secondary breast cancer? I was diagnosed with SBC on 16th March 2020.

You may have steroids as part of your treatment or to control symptoms and help you to feel better. Steroids may be given: with certain chemotherapy drugs to prevent an allergic reaction or to reduce sickness to reduce swelling and control pain when there is a secondary cancer in the liver to reduce pressure and relieve headaches and sickness when there is a secondary cancer in the brain.

When were you diagnosed with secondary breast cancer? March 2016 confirmed.

Continuing on our Sunday series of educational blogs around secondary breast cancer treatments; this week we are highlighting Immunotherapy.

Have you had experience of this? 

Continuing our series of blogs on treatments you may have for secondary breast cancer, this week we’re focusing on Electrochemotherapy.

Do you have experience of this treatment?

Whole Brain Radiotherapy [WBRT] is given when cancer cells from another part of the body have spread to and developed in the brain. The aim of the WBRT is to help relieve any symptoms or prevent symptoms from developing and to slow down the growth of the cancer.

Let’s find out more about Portacaths. Chemotherapy requires people to receive frequent doses of intravenous therapy over a long period; a portacath is a small piece of medical equipment that can make this procedure more comfortable for patients.

We published research in October with YouGov - 38% of the adult population in the UK don't know what secondary breast cancer is. This highlights the massive gap in awareness and education of secondary breast cancer and the work that needs done to change this.